Diane Stone

533 total citations
16 papers, 435 citations indexed

About

Diane Stone is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Diane Stone has authored 16 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Hematology. Recurrent topics in Diane Stone's work include Hematopoietic Stem Cell Transplantation (6 papers), T-cell and B-cell Immunology (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Diane Stone is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), T-cell and B-cell Immunology (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Diane Stone collaborates with scholars based in United States, Italy and Germany. Diane Stone's co-authors include Yukang Lin, Donald B. Axworthy, Oliver W. Press, Rainer Storb, Scott S. Graves, Robert W. Mallett, Jody Schultz, James Sanderson, Don B. Axworthy and Sibylle Wilbert and has published in prestigious journals such as Blood, Transplantation and Digestive Diseases and Sciences.

In The Last Decade

Diane Stone

16 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane Stone United States 11 259 104 99 93 73 16 435
G. Vierwinden Netherlands 11 100 0.4× 115 1.1× 28 0.3× 52 0.6× 117 1.6× 14 390
Erika M. Cook United States 9 172 0.7× 224 2.2× 75 0.8× 106 1.1× 150 2.1× 18 433
Christophe Arnoult France 10 158 0.6× 199 1.9× 17 0.2× 72 0.8× 139 1.9× 15 420
Kaitlyn Rogers United States 6 336 1.3× 153 1.5× 53 0.5× 138 1.5× 161 2.2× 11 482
George L. Manderino United States 13 58 0.2× 74 0.7× 32 0.3× 95 1.0× 151 2.1× 25 370
Tiffany A. Coupet United States 5 160 0.6× 204 2.0× 18 0.2× 323 3.5× 128 1.8× 7 428
Anton Neschadim Canada 16 105 0.4× 182 1.8× 21 0.2× 146 1.6× 253 3.5× 27 629
Wenxu Zhao China 7 137 0.5× 96 0.9× 26 0.3× 171 1.8× 176 2.4× 19 374
S. Goldberg United States 11 63 0.2× 288 2.8× 23 0.2× 182 2.0× 124 1.7× 15 439
MW Fanger United States 8 118 0.5× 157 1.5× 49 0.5× 71 0.8× 146 2.0× 12 417

Countries citing papers authored by Diane Stone

Since Specialization
Citations

This map shows the geographic impact of Diane Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Stone more than expected).

Fields of papers citing papers by Diane Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Stone. The network helps show where Diane Stone may publish in the future.

Co-authorship network of co-authors of Diane Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Stone. A scholar is included among the top collaborators of Diane Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Stone. Diane Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Parker, Maura H., et al.. (2020). Anti-ICOS mAb Targets Pathogenic IL-17A-expressing Cells in Canine Model of Chronic GVHD. Transplantation. 105(5). 1008–1016. 2 indexed citations
2.
Graves, Scott S., Boglarka Gyurkocza, Diane Stone, et al.. (2019). Development and characterization of a canine-specific anti-CD94 (KLRD-1) monoclonal antibody. Veterinary Immunology and Immunopathology. 211. 10–18. 14 indexed citations
3.
Graves, Scott S., Maura H. Parker, Diane Stone, et al.. (2017). Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 24(1). 50–54. 8 indexed citations
4.
Graves, Scott S., Andrew R. Rezvani, George Sale, et al.. (2016). A Canine Model of Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 23(3). 420–427. 10 indexed citations
5.
Rosinski, Steven Lawrence, Rainer Storb, Roland K. Strong, et al.. (2015). Anti-CD28 Antibody-Initiated Cytokine Storm in Canines. Transplantation Direct. 1(2). 1–11. 20 indexed citations
6.
7.
Graves, Scott S., Diane Stone, Carol Loretz, et al.. (2011). Antagonistic and Agonistic Anti-canine CD28 Monoclonal Antibodies: Tools for Allogeneic Transplantation. Transplantation. 91(8). 833–840. 22 indexed citations
8.
Graves, Scott S., Diane Stone, Carol Loretz, et al.. (2009). Establishment of Long-Term Tolerance to SRBC in Dogs by Recombinant Canine CTLA4-Ig. Transplantation. 88(3). 317–322. 20 indexed citations
9.
Jochum, Christoph, Mechthild Beste, Diane Stone, Scott S. Graves, & Rainer Storb. (2008). Development and in vitro characterization of canine CD40-Ig. Veterinary Immunology and Immunopathology. 123(3-4). 260–265. 7 indexed citations
10.
Pantelias, Anastasia, John M. Pagel, Donald K. Hamlin, et al.. (2007). Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas. Blood. 109(11). 4980–4987. 29 indexed citations
11.
12.
Weiden, Paul L., Hazel B. Breitz, Oliver W. Press, et al.. (2000). Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study Results. Cancer Biotherapy and Radiopharmaceuticals. 15(1). 15–29. 110 indexed citations
13.
Schultz, Jody, Yukang Lin, James Sanderson, et al.. (2000). A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.. PubMed. 60(23). 6663–9. 108 indexed citations
14.
Breitz, Hazel B., P L Weiden, Joy Applebaum, et al.. (1999). Pretargeted Radioimmunotherapy (PRITR) for Treatment of Non-Hodgkin's Lymphoma (NHL): Preliminary Results. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 40. 1 indexed citations
15.
Graves, Scott S., Diane Stone, Don B. Axworthy, et al.. (1999). Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody.. PubMed. 5(4). 899–908. 8 indexed citations
16.
Hofmann, Alan F., Kathryn F. Witztum, Joseph H. Steinbach, et al.. (1987). Limitations of indirect methods of estimating small bowel transit in man. Digestive Diseases and Sciences. 32(7). 689–699. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Vierwinden Breakdown of academic impact, for papers by Erika M. Cook Breakdown of academic impact, for papers by Christophe Arnoult Breakdown of academic impact, for papers by Kaitlyn Rogers Breakdown of academic impact, for papers by George L. Manderino Breakdown of academic impact, for papers by Tiffany A. Coupet Breakdown of academic impact, for papers by Anton Neschadim Breakdown of academic impact, for papers by Wenxu Zhao Breakdown of academic impact, for papers by S. Goldberg Breakdown of academic impact, for papers by MW Fanger
Rankless by CCL
2026